Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 2.74 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 1.95 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 2.09 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 1.68 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 1.78 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 2.35 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 2.51 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 3.71 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 0.0 | BCD100427B001 | 1.69 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 0.5 | BCD100427B003 | 2.51 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 1.0 | BCD100427B007 | 1.62 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 2.0 | BCD100427B011 | 1.19 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 4.0 | BCD100427B015 | 1.56 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 8.0 | BCD100427B019 | 2.49 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 12.0 | BCD100427B023 | 3.47 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | C | 24.0 | BCD100427B027 | 3.42 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 1.65 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 2.59 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 1.69 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 3.18 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 3.32 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 4.13 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 5.08 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 1.86 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 1.79 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 1.96 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 2.15 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 2.98 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 2.68 | pmol/sample |
| LMFA01030130 | 11,14-eicosadienoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 4.72 | pmol/sample |